Niagen Bioscience, Inc. Cash Flow Reinvestment Rate
Niagen Bioscience, Inc. cash flow reinvestment rate. Niagen Bioscience, Inc. (NAGE) has a Cash Flow Reinvestment Rate of 0.03x as of June 2026, reinvesting $89.00K (capex $89.00K ) from operating cash flow of $2.77 Million. Explore Niagen Bioscience, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Niagen Bioscience, Inc. (2023–2025)
Cash flow reinvestment rate of Niagen Bioscience, Inc. from 2023 to 2025. Historical reinvestment intensity for Niagen Bioscience, Inc. across 3 annual periods. Explore Niagen Bioscience, Inc. capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Niagen Bioscience, Inc. Cash Flow Reinvestment Rate by Year (2023–2025)
Niagen Bioscience, Inc. cash flow reinvestment rate by year from 2023 to 2025. Year-by-year capital reinvestment analysis for Niagen Bioscience, Inc.. For the full cash flow conversion analysis, see Niagen Bioscience, Inc. cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | $292.00K | $13.44 Million | $292.00K | ▼ -14.0% |
| 2024 | 0.03x | $306.00K | $12.11 Million | $163.00K | ▼ -38.2% |
| 2023 | 0.04x | $291.00K | $7.12 Million | $148.00K | — |